Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase

Author:

Messore Antonella1,Corona Angela2ORCID,Madia Valentina Noemi1,Saccoliti Francesco3,Tudino Valeria1,De Leo Alessandro1,Ialongo Davide1,Scipione Luigi1ORCID,De Vita Daniela4,Amendola Giorgio5ORCID,Novellino Ettore6ORCID,Cosconati Sandro5ORCID,Métifiot Mathieu7,Andreola Marie-Line7,Esposito Francesca2,Grandi Nicole2,Tramontano Enzo2ORCID,Costi Roberta1ORCID,Di Santo Roberto1ORCID

Affiliation:

1. Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, p.le Aldo Moro 5, I-00185 Rome, Italy

2. Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, SS554-09042 Monserrato (CA), Italy

3. D3 PharmaChemistry, Italian Institute of Technology, Via Morego 30, I-16163 Genova, Italy

4. Department of Environmental Biology, “Sapienza” University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy

5. DiSTABiF, University of Campania “Luigi Vanvitelli”, Via Vivaldi 43, 81100 Caserta, Italy

6. Department of Pharmacy, University Federico II of Naples, Via D. Montesano 49, 80131 Naples, Italy

7. Laboratoire MFP, UMR 5234, CNRS - Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux cedex, France

Funder

Sapienza Universit?? di Roma

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference69 articles.

1. UNAIDS. Global AIDS Update 2020. https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf (accessed Aug 20, 2020).

2. NIH. FDA-approved HIV medicines. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/58/fda-approved-hiv-medicines (accessed Feb 18, 2021).

3. NYSDOH. HIV guidelines. https://www.hivguidelines.org/antiretroviral-therapy/what-to-start/#tab_1 (accessed Feb 18, 2021).

4. The Use of Highly Active Antiretroviral Therapy (HAART) in Patients With Advanced HIV Infection

5. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other “Shock” Drugs

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3